Last reviewed · How we verify

NCT06017596

CAD-CAM PEEK Framework for All-on-4 Implants

Completed NA Last updated 30 August 2023
What this trial tests

NA trial testing PEEK framework in Bone Loss in 16 participants. Completed in 20 March 2023.

Timeline
23 February 2021
Primary endpoint
12 February 2023
20 March 2023

Quick facts

Lead sponsorMansoura University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment16
Start date23 February 2021
Primary completion12 February 2023
Estimated completion20 March 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University

Who can join

Adults 60 to 70, any sex, with Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to evaluate the clinical peri-implant soft tissue changes during the first year after occlusal loading and the ridge base relation after 3 years for mandibular computer-aided design and computer-aided manufacturing (CAD/CAM) screw-retained implant-supported hybrid prosthesis of polyetheretherketone (PEEK) framework utilized with All-on-Four treatment concept.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bone Loss

Currently open trials in the same condition.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06017596.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing